Recent News

  • Avivagen Announces Clarification to Press Release Issued November 19, 2018

    Ottawa, ON / TNW-Accesswire / November 19, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”), announces a clarification to its press release issued Monday, November 19th at 6:30 A.M. EST. The previous NR had stated that UNAHCO’s year-to-date purchase of OxC-beta™ Livestock was 9.1 metric tonnes. UNAHCO has purchased 7.2 metric tonnes calendar year-to-date, 8.4 metric …Read More

  • Avivagen’s Asian Partner Unahco Continues To Ramp-up Use Of Oxc-beta™ Livestock With New Large Order

    Ottawa, ON / TNW-Accesswire / November 19, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tonnes of OxC-beta™ Livestock. This follows a 2 metric tonne order delivered to UNAHCO in September 2018 and brings its year-to-date purchase of OxC-beta™ Livestock to …Read More

  • World Health Organization’s “World Antibiotic Awareness Week” Highlights the Need for Avivagen’s Products

    Ottawa, ON /GlobeNewswire/ November 15, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, strongly endorses the World Health Organization’s (WHO) initiative to declare “World Antibiotic Awareness Week,” from November 12-18, 2018. Among the known uses that create antibiotic resistance is the overuse …Read More

  • Avivagen Announces Distribution Agreement for Vivamune™ in Vietnam

    Ottawa, ON /GlobeNewswire/ October 18, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has entered into a distribution agreement for Vivamune™ Health Chews in the Vietnamese market with Viphavet Co. Ltd. This agreement reflects new interest in the Vivamune™ Health Chews product and opens up a new territory for Avivagen …Read More

  • Avivagen Announces Distribution Agreement for OxC-beta™ Livestock in Malaysia

    Ottawa, ON / TNW-Accesswire / October 11, 2018 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has signed its first distribution agreement for OxC-beta™ Livestock in Malaysia. With a total annual feed production of 4.4 million metric tonnes, the Malaysian market is dominated by feed for poultry broilers and layers1.  This …Read More

View All News Releases

Media Coverage

  • VICTAM Asia

    Avivagen CEO Interviewed at VICTAM Asia 2018 Conference

    Avivagen recently debuted at the VICTAM ASIA 2018 Conference in Bangkok, Thailand.

  • CEO Kym Anthony Interviewed by Uptick

    CEO Kym Anthony was interviewed by the penny stock news and trends podcast, Uptick Newswire.

    I think if people keep their eyes on the size of the prize, [they’ll see] the livestock market is in the billions of dollars; our share of that would be in the hundreds of millions if we roll out successfully. The human market is untouched. The companion animal market is also big. We’ve spent years proving it works; everyone agrees it works. Now is the time to roll it out commercially.

  • CTV: Growing resistance to antibiotics fuels market for alternative solutions

    CTV NEWS, TORONTO – A hundred years ago, a small wound could result in death if an infection spread. That could become reality again as the world threatens to return to a pre-antibiotic era due to antibiotic resistance.

    Some have pointed to the widespread use of antibiotics in livestock feed as a culprit, resulting in urgent calls to quell their use and find alternatives.

View All Media Coverage